Download FREE Report Sample
Download Free sampleGranulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.
Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.
G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.
Recombinant Human Granulocyte Colony-Stimulating Market contains market size and forecasts of Recombinant Human Granulocyte Colony-Stimulating in global, including the following market information:
Global Recombinant Human Granulocyte Colony-Stimulating Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Human Granulocyte Colony-Stimulating Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Recombinant Human Granulocyte Colony-Stimulating companies in 2021 (%)
The global Recombinant Human Granulocyte Colony-Stimulating market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lenograstim (Granocyte) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Granulocyte Colony-Stimulating include Amgen, Qilu Pharmaceutical, Shijiazhuang Pharmaceutical, Kyowa Hakko Kirin, Gensci, Amoytop Biotech, Hangzhou Jiuyuan, Huaxin and Triprime, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Human Granulocyte Colony-Stimulating manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Granulocyte Colony-Stimulating Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Human Granulocyte Colony-Stimulating Market Segment Percentages, by Type, 2021 (%)
Global Recombinant Human Granulocyte Colony-Stimulating Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Human Granulocyte Colony-Stimulating Market Segment Percentages, by Application, 2021 (%)
Global Recombinant Human Granulocyte Colony-Stimulating Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Recombinant Human Granulocyte Colony-Stimulating Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
